Blogs/Publications, Competitor News, Events, Marketing, RWE Study

Flatiron Health Announces Research to be Presented at American Society of Clinical Oncology 2023 Annual Meeting

May 25, 2023 05:05 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced that the company and its collaborators will present a total of 12 abstracts accepted for poster discussion, presentation, and online publication at this year’s American Society of Clinical Oncology (ASCO) Annual meeting, to be held in…

Competitor News, Product Updates

HealthVerity FLOW launched to synchronize the pharmaceutical product lifecycle

Delivers consolidated governance and real-world data exchange to unlock insights from registries and clinical trials to commercial and beyond PHILADELPHIA, May 23, 2023 /PRNewswire/ — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the launch of HealthVerity FLOW, a pharma-class Software-as-a-Service solution that…

Partner and Collaborator News

C&A and Palantir Develop Artificial Intelligence Model to Optimize the Product Purchasing and Inventory Restocking Process

DENVER, May 23, 2023 /PRNewswire/ — Today, Palantir Technologies Inc. (NYSE: PLTR) (“Palantir”), a leading builder of operating systems for the modern enterprise, and C&A Modas S.A (“C&A”), one of the largest retail chains in the fashion world, announced the development of an Integrated Management Flow system using the Palantir Foundry platform. The…

Competitor News, RWE Study

ATCOR Launches New 2,000-Patient Longitudinal Retrospective Study for Heart Health

“Gold Standard” SphygmoCor® Technology to be Used to Identify Care Outcomes Associated with Routine Monitoring of Patients with Elevated Blood Pressure IRVINE, Calif., May 22, 2023 /PRNewswire/ — ATCOR Medical, a subsidiary of CardieX and developer of innovative medical devices and digital health solutions to optimize hypertension management and improve clinical trial patient outcomes, today announced…

Academic, Collaborations, Competitor News, Data Partnership, Europe, International

France’s CHRU de Nancy Joins the TriNetX Network to Strengthen Investigator-Initiated Research Output and Patient Access to Innovative Therapies

Nancy, France, May 22, 2023 — The Centre Hospitalier Régional Universitaire (CHRU) de Nancy, one of the leading research institutions in France, announced it is partnering with TriNetX to attain access to global real-world data (RWD) to generate real-world evidence (RWE) in support of investigator-initiated research, as well as provide greater…

Collaborations, Competitor News, Pharma

Yaral Pharma Partners With EVERSANA to Support the Commercialization of Its Expanding Generics Portfolio

Partnership Supports Commitment to Providing High-Quality Products, Supply Chain Continuity, and Exceptional Customer Service May 22, 2023 08:00 AM Eastern Daylight Time PARSIPPANY, N.J.–(BUSINESS WIRE)–Yaral Pharma Inc., (Yaral Pharma) the United States generics subsidiary of IBSA (Institut Biochimique SA), today announced its expanding partnership with EVERSANA®, a leading provider of commercialization…

Competitor News, RWE Study

Latest Research from Clarify Health Institute Uncovers Key Trends and Diagnoses in Mental Health Crisis Among US Children and Young Adults

May 18, 2023 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–The number of mental health hospitalizations among children and young adults more than doubled from 2016 to 2022, with hospitalizations for anxiety and fear-related disorders, and feeding and eating disorders tripling according to new research titled “The Kids Are Not Alright:…

Canada, Collaborations, Competitor News, Data Partnership, International, Synthetic Data

Nova Scotia Health Launches Pilot Program with MDClone

New partnership improves patient care by giving researchers better, more efficient health data access. Mar. 17, 2023 — Nova Scotia Health is partnering with MDClone – a global data analytics and synthetic data company – to enable quick access for clinicians to health data while maintaining the strictest privacy considerations….

Collaborations, Competitor News

Myovant Sciences and Evidation Announce Survey Results of Unseen Burdens at Work and School of Individuals with Endometriosis and/or Uterine Fibroids

May 17, 2023 09:00 AM Eastern Daylight Time SAN MATEO, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Today, as part of National Women’s Health Week, Evidation and Myovant Sciences Ltd. (“Myovant”), a wholly owned subsidiary of Sumitovant Biopharma Ltd. (“Sumitovant”) announced results from a survey exploring the lived experiences of individuals with endometriosis…